188 related articles for article (PubMed ID: 35096881)
1. Role of a Pyroptosis-Related lncRNA Signature in Risk Stratification and Immunotherapy of Ovarian Cancer.
Zhang Z; Xu Z; Yan Y
Front Med (Lausanne); 2021; 8():793515. PubMed ID: 35096881
[No Abstract] [Full Text] [Related]
2. Identification and validation of a novel pyroptosis-related lncRNAs signature associated with prognosis and immune regulation of hepatocellular carcinoma.
Zhang Z; Xia F; Xu Z; Peng J; Kang F; Li J; Zhang W; Hong Q
Sci Rep; 2022 May; 12(1):8886. PubMed ID: 35614201
[TBL] [Abstract][Full Text] [Related]
3. Derivation, Comprehensive Analysis, and Assay Validation of a Pyroptosis-Related lncRNA Prognostic Signature in Patients With Ovarian Cancer.
Cao X; Zhang Q; Zhu Y; Huo X; Bao J; Su M
Front Oncol; 2022; 12():780950. PubMed ID: 35280739
[TBL] [Abstract][Full Text] [Related]
4. Role of an Exosomes-Related lncRNAs Signature in Tumor Immune Microenvironment of Gastric Cancer.
Li C; Zhang Z; Peng E; Peng J
Front Cell Dev Biol; 2022; 10():873319. PubMed ID: 35465325
[No Abstract] [Full Text] [Related]
5. A Novel Pyroptosis-Associated Long Non-coding RNA Signature Predicts Prognosis and Tumor Immune Microenvironment of Patients With Breast Cancer.
Ping L; Zhang K; Ou X; Qiu X; Xiao X
Front Cell Dev Biol; 2021; 9():727183. PubMed ID: 34616734
[No Abstract] [Full Text] [Related]
6. Identification and Validation of a Three Pyroptosis-Related lncRNA Signature for Prognosis Prediction in Lung Adenocarcinoma.
Liu J; Liu Q; Shen H; Liu Y; Wang Y; Wang G; Du J
Front Genet; 2022; 13():838624. PubMed ID: 35928454
[TBL] [Abstract][Full Text] [Related]
7. A pyroptosis-related lncRNA signature in bladder cancer.
Wang P; Wang Z; Zhu L; Sun Y; Castellano L; Stebbing J; Yu Z; Peng L
Cancer Med; 2023 Mar; 12(5):6348-6364. PubMed ID: 36237132
[TBL] [Abstract][Full Text] [Related]
8. Identification of a pyroptosis-associated long non-coding RNA signature for predicting the immune status and prognosis in skin cutaneous melanoma.
Wu L; Liu G; He YW; Chen R; Wu ZY
Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5597-5609. PubMed ID: 34604952
[TBL] [Abstract][Full Text] [Related]
9. A prognostic exosome-related LncRNA risk model correlates with the immune microenvironment in liver cancer.
Su D; Zhang Z; Xu Z; Xia F; Yan Y
Front Genet; 2022; 13():965329. PubMed ID: 36081999
[No Abstract] [Full Text] [Related]
10. A novel pyroptosis-related lncRNA prognostic signature associated with the immune microenvironment in lung squamous cell carcinoma.
Zhou W; Zhang W
BMC Cancer; 2022 Jun; 22(1):694. PubMed ID: 35739504
[TBL] [Abstract][Full Text] [Related]
11. A Potential Immune-Related Long Non-coding RNA Prognostic Signature for Ovarian Cancer.
Pan X; Bi F
Front Genet; 2021; 12():694009. PubMed ID: 34367253
[TBL] [Abstract][Full Text] [Related]
12. Immune cell death-related lncRNA signature as a predictive factor of clinical outcomes and immune checkpoints in gastric cancer.
Zhang Z; Su D; Thakur A; Zhang K; Xia F; Yan Y
Front Pharmacol; 2023; 14():1162995. PubMed ID: 37081965
[No Abstract] [Full Text] [Related]
13. Pyroptosis-Related LncRNA Signature Predicts Prognosis and Is Associated With Immune Infiltration in Hepatocellular Carcinoma.
Liu ZK; Wu KF; Zhang RY; Kong LM; Shang RZ; Lv JJ; Li C; Lu M; Yong YL; Zhang C; Zheng NS; Li YH; Chen ZN; Bian H; Wei D
Front Oncol; 2022; 12():794034. PubMed ID: 35311105
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of pyroptosis-related gene landscape in prognosis and immunotherapy of ovarian cancer.
Gao L; Ying F; Cai J; Peng M; Xiao M; Sun S; Zeng Y; Xiong Z; Cai L; Gao R; Wang Z
J Ovarian Res; 2023 Jan; 16(1):27. PubMed ID: 36707884
[TBL] [Abstract][Full Text] [Related]
15. A Novel lncRNA Panel Related to Ferroptosis, Tumor Progression, and Microenvironment is a Robust Prognostic Indicator for Glioma Patients.
He Y; Ye Y; Tian W; Qiu H
Front Cell Dev Biol; 2021; 9():788451. PubMed ID: 34950662
[No Abstract] [Full Text] [Related]
16. Identification of a pyroptosis-related long non-coding RNA Signature for prognosis and its related ceRNA regulatory network of ovarian cancer.
Xu H; Lu M; Liu Y; Ren F; Zhu L
J Cancer; 2023; 14(16):3151-3168. PubMed ID: 37859811
[No Abstract] [Full Text] [Related]
17. Construction of prognostic signature of patients with oral squamous cell carcinoma based on pyroptosis-related long non-coding RNAs.
Xin Y; Zhang J; Jiang Q; Qiu J
Front Surg; 2022; 9():935765. PubMed ID: 36211292
[TBL] [Abstract][Full Text] [Related]
18. Identification and Validation of Pyroptosis-Related lncRNA Signature and Its Correlation with Immune Landscape in Soft Tissue Sarcomas.
Lin Z; Xu Y; Zhang X; Wan J; Zheng T; Chen H; Chen S; Liu T
Int J Gen Med; 2021; 14():8263-8279. PubMed ID: 34815699
[TBL] [Abstract][Full Text] [Related]
19. Clinical Significance and Immune Landscape of a Pyroptosis-Derived LncRNA Signature for Glioblastoma.
Xing Z; Liu Z; Fu X; Zhou S; Liu L; Dang Q; Guo C; Ge X; Lu T; Zheng Y; Dai L; Han X; Wang X
Front Cell Dev Biol; 2022; 10():805291. PubMed ID: 35223836
[No Abstract] [Full Text] [Related]
20. Identification and validation of an immune-related lncRNAs signature to predict the overall survival of ovarian cancer.
Li H; Liu ZY; Chen YC; Zhang XY; Wu N; Wang J
Front Oncol; 2022; 12():999654. PubMed ID: 36313727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
